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Abstract
The most recent data published in December 2019 records that approximately
736,900 registered cochlear implantation devices have been received since their approval
in the 1980s. While 183,100 of these devices belong to U.S. Citizens, the large majority
of cochlear implant recipients live in other countries (U.S. Department of Health and
Human Services, 2016). While a lack of standardized practices exists in relation to
audiologic care and management of cochlear implant devices and patients, Browning et
al. (2020) attempts to assess and analyze common practices amongst audiologists
practicing within the United States of America. This survey uses a modified
questionnaire based on Browning et al. (2020) as well as an international survey of
clinical cochlear implantation practices by Vaerenberg et al., (2014) to further track
similarities and differences among cochlear implant professionals in India to better
understand the clinical practice of cochlear implantation worldwide.
Cochlear implant audiologists or other trained professionals involved in the
cochlear implant fitting process may benefit from this research as it expands the
knowledge of common cochlear implant fitting and follow-up practices in India and
compares this data with what is known about similar clinical cochlear implant processes
in the United States from a similar study by Browning et al. (2020).

ix
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Introduction
Cochlear implant devices are known to be the most cost-effective solution to
significant hearing loss (World Health Organization, 2017). In 2018, the World Health
Organization estimated that approximately 466 million people were living with a
significant hearing loss. This organization projects that by 2050, over 900 million people
around the world will be affected by debilitating hearing loss, with a disproportionately
high amount of those affected living in lower income countries (World Health
Organization, 2017). Despite this fact, most of the published research to date following
the clinical protocols for cochlear implantation are focused on higher income countries
like the United States and other western European countries, like the surveys by
Browning et al. (2020), Vaerenberg et al. (2014), and Scherf et al. (2014).
The present survey intends to begin to fill in the gaps of knowledge currently
surrounding the cochlear implant clinical protocols in one of the largest emerging
cochlear implant markets: India. The country of India is of particular interest as it has
been influencing the development of government-assisted programs in surrounding
nations such as Nepal, Sri Lanka, and Bangladesh (Kumar & Kameswaran, 2017). The
Cochlear Implant Group of India is a professional organization that has formed to give
guidance to practicing cochlear implant professionals in the country; however, their
recommendations are non-binding and mostly focus on cochlear implant candidacy rather
than device programming and follow up care (The Cochlear Implant Group of India,
2018).
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Browning et al. (2020) found a similar circumstance in the United States and sent
out a survey to fill in the gap of knowledge surrounding these clinical programming and
follow up practices in the country. The present survey is an extension of the Browning et
al. (2020) survey after being modified for clarity and cultural considerations. Although
the Cochlear Implant Group of India (2018) does not provide programming, otherwise
known as MAPping recommendations, each cochlear implant manufacturer provides
default programming choices that can be changed by the clinician during a MAPping
appointment. Do clinicians in India prefer the default parameters like Browning et al.
found in their survey? Is a preference for default parameters correlated with cochlear
implant experience? These questions will be explored in the present study.
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Methods
Participants
22 audiologists who self-identified as specializing in cochlear implants working in
India fully completed this survey. Potential candidates for this survey were selected by
personal contacts and membership through Indian-based audiology organizations. Survey
candidates provided their email addresses and were sent a link to the survey, which was
available via QuestionPro using a JMU license. The respondents were met with a
statement explaining the creators of the survey, the purpose of the survey, the estimated
completion time, and definitions for the subjects of certain questions in the survey such
as adults, pediatrics, and mapping. See Appendix II for the introductory statement.
Responses to the survey were anonymous. This survey was approved by the Institutional
Review Board at James Madison University and is listed as Protocol ID 22-2901. Seventy
four total unique Indian IP addresses attempted this survey, while 22 fully completed the
full questionnaire and 52 dropped out (30% completion rate).
Questionnaire
Before creating the survey through QuestionPro, the questionnaire was developed
to evaluate cochlear implant programming practices, objective measurements, subjective
measurements, bimodal fitting practices, and habilitation/ rehabilitation practices for
Indian cochlear implant audiologists and other professionals working in India who may
perform these tasks. This questionnaire is a modified version of Browning et al. 2020’s
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questionnaire used to assess these same parameters in the cochlear implant audiologists
of the United States. In the Browning et al. development of the questionnaire, the authors
carefully created questions, undergoing twelve different versions that were critiqued by
cochlear implant manufacturer representatives and cochlear implant clinical audiologists
in the U.S. until the final version was approved for distribution. Similar to the
development of the Browning et al. (2020) survey, The questionnaire from Vaerenberg et
al. (2014) was considered as well as the questionnaire by Jeyaraman (2013), as this
survey was specifically focused on the general cochlear implant practice and programs in
India. With these two publications in mind, the current survey strives to build on the
existing published knowledge of international, namely Indian, data.
The changes in the questionnaire for the present survey were reviewed and
approved by the authors of this paper and their personal contacts who are working
professionals in both the United States and India for clarity and cultural considerations.
For instance, questions concerning the financial responsibility of the surgery and services
were added since according to the author’s personal contacts in India as well as
Jeyaraman (2013), many government-assisted programs are well known and available in
India for children who are cochlear implant candidates. Participants could choose to
complete the survey in one sitting, or the survey had the option to save the participant’s
progress so that they could return to the survey to complete it at their convenience.
Once the survey was initiated, the first questions inquired about the participant’s
current clinical setting including their role in the clinical team, how many cochlear
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implants they have personally activated, the general clinical setting in which they work,
relevant services provided, and financial coverage of the device and services. Next
questions related to clinical decision making such as who decides the manufacturer used,
how many manufacturers the participant actively works with, pre-operative counseling,
and frequency of off-label implantation. Next, participants were asked about mapping
procedures for each of the manufacturers. If a participant did not work with a select
manufacturer, they were prompted to not answer those specific questions. The next
section inquired about objective measurements for pediatric patients and adult patients.
Following this section, the participants were asked about their bimodal fitting
preferences. Finally, questions concerning the recommendation of habilitation/
rehabilitation in cochlear implant patients appeared. At the conclusion of the survey, a
free response box was available for any further comments the participant would like to
add.
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Results
Clinical Setting
All of the respondents self-identified as audiologists in the cochlear implant team.
Of these audiologists, all were clearly knowledgeable in the fitting and follow up
practices of cochlear implants based on their responses to the next two questions. The
first question inquired about the approximate number of adult devices that the respondent
personally activated, while the second question inquired the same about pediatric devices.
While the responses for adults were few, ranging from 0 to 230, the pediatric activations
were significantly higher, ranging from 0 to 1,600, with many of the respondents
estimating their experience to be within hundreds and over a thousand pediatric
activations.
Although all of the respondents were audiologists, their clinical settings were
more diverse. The spread of clinical settings found that the majority of the participants
worked in a privately owned audiology clinic (33%). This was closely followed by a tie
of 26% working in a medical college hospital and the same number working in an
institution clinic. Audiologists working in an otolaryngologist’s practice made up 11% of
the respondents and 4% of the participants indicated they worked in a non-listed setting.
See Figure 1.
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Figure 1. Clinical settings in which cochlear implant mapping is performed in India

Clear trends emerged for services offered at these differing settings. Medical or
ENT services were offered at 71% of these clinical settings. The actual cochlear implant
surgery was available at 48% of the workplaces. Auditory rehabilitation/ habilitation was
offered at all of the settings. Services for fitting hearing aids was available at 91% of the
practices. This may be an important factor for bimodal recommendations in future
research. Vestibular assessment was available at 77% of the settings, and 64% of the
practices offered psychological evaluations. In the free response section, other relevant
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services that were offered at some settings that the respondents felt were relevant to this
line of questioning included radiological evaluation, genetic counseling, and social
services. See Figure 2.
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Figure 2. Different clinical services offered at the cochlear implant audiologist’s work
setting in India. Solid filled bars indicate the proportion of audiologists indicating the
availability of a particular service. Hatched bars represent patient referral to other clinics.
Financial Considerations
The respondents were asked a question to identify various avenues for payment of
cochlear implantation. Options included subsidized payment under a government scheme,
total out of pocket payment, private insurance, other means (e.g. international aid groups)
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and unknown. The respondents could select multiple options since the patient population
in any clinic can vary in terms of paying for healthcare. Out of the 22 audiologists, 18
reported that some patients in their clinic are covered by the government schemes for
reduced cost/free cochlear implantation (82%). Out of pocket payment for implantation
was also identified as another common method of paying for services (also 18 out of the
22 audiologists). Upon an inspection of the individual responses it was confirmed that the
18 audiologists selecting the two responses did not overlap. There were 15 audiologists
who selected both options as a mode of payment in their clinics. A smaller group of
audiologists (4 out of the 22) responded that private insurance pays for the cochlear
implantation in their clinics. The results obtained from this question provides a reflection
of the various types of payment accepted at a clinic.
For those settings that participated in government assisted programs,
approximately one-third (37%) indicated that between 76%-100% of patients participated
in these offerings. Another 37% answered that approximately 51%-75% of patients at
their facility received this assistance. Another 10% audiologists in this survey responded
that every patient received help from these government services. A smaller group (5%)
responded that only 25%-50% received government assisted services. Also, 11%
indicated that less than 25% of their patients qualified. These findings provide additional
information about government funded CI programs in the country. There are two
audiologists whose work setting primarily caters to low income patients by providing
cochlear implants are free or subsidized costs.
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Figure 3. Proportion of audiologists reporting the share of their cochlear implant caseload
funded by the government free/subsidized payment schemes.

Clinical Decision Making
It was of interest to survey the audiologists about the nature of decision making
while selecting a cochlear implant manufacturer. The respondents were asked to select a
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category from always, most of the time, about half of the time, sometimes, or never.
When asked about the importance of the surgeon’s preference for the CI model, 40%
selected “most of the time”. The rest of the categories are shown in figure 4 below.

Figure 4. Surgeon’s preference as a deciding factor in the selection of cochlear implant
manufacturer.
Similarly, the audiologist’s recommendation and the patient’s preference were
also examined as deciding factors in the final selection of the cochlear implant. Figures 5
and 6 summarize the results below. Another limiting factor in selecting a particular
manufacturer of cochlear implant depends on the variety of manufacturers’ products
available at a particular clinic. Some clinics exclusively work with one cochlear implant
manufacturer. In such a case, surgeon preference, audiologist recommendation or patient
preference do not matter. Figure 7 shows the frequency this is a deciding factor.
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Audiologist Recommendation
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Figure 5. Importance of the audiologist’s recommendation in the final selection of
cochlear implant manufacturer.
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Patient Preference
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Figure 6. Importance of the patient’s preference in the final selection of cochlear implant
manufacturer.
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Figure 7. Proportion of clinical settings where only one cochlear manufacturer is offered
to the patient.
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Cochlear Implant Manufactures
The next section of the survey explored which cochlear implant manufacturers are
most commonly used by the audiologists in India. All 22 participants (100%) responded
that they work with implants manufactured by Cochlear Corporation. MED-EL (77.27%)
and Advanced Bionics (68.18%) were also selected as CI manufacturers who they work
with. Oticon Medical’s Digisonic cochlear implants are a new entrant in India. Only 32%
audiologists indicated that they work with Digisonic implants. One participant reported
that they work with Digisonic implants if the patient receives a government grant to pay
for the cochlear implants.
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Figure 8. Number of audiologists (out of 22 participants) identifying the cochlear implant
manufacturers they work with. As can be seen from this figure, most audiologists work
with multiple cochlear implant manufacturers.
Pre-implantation counseling and off-label implantation
Pre-implantation counseling is an important step in the cochlear implantation
process. The respondents reported that audiologists (100%) and otolaryngologists (86%)
are involved in counseling patients and their families prior to the implantation. The
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patients also benefit from meetings with other professionals such as psychologists (32%)
and speech language pathologists (68%). Pre-implantation counseling data is displayed in
figure 9. Off label cochlear implantation refers to cases where surgery is performed
without strict adherence to approved candidacy criteria. Such instances may be warranted
in cases of congenital malformations or ossification of the cochlea. The audiologists
participating in this survey reported that off-label cochlear implantation is uncommon at
their clinical sites ranging from 0% - 20%.

Pre-implantation Counseling
100
86

100

80

68

60

40

32
23

20
0
ENT surgeon

Audiologist

Psychologist

SLP

Other
professional

Figure 9.. Pre-implantation counseling by different members of the cochlear implant
team. While the otolaryngologist and the audiologist spend time counseling prior to the
implantation, other professionals are also involved in the process.
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Preferences for Default MAPping Parameters
When MAPping Cochlear devices, data trends revealed at least 80% or more of
the respondents indicated that they always or almost always prefer the default settings for
all of the parameters which were evaluated in the survey. See Figure 10 for a visual
representation of the preference for Cochlear default parameters. Please see Appendix II
for the specific parameters. For MED-EL, at least 80% of the responses indicated always
or almost always as the preference was found for all the parameters. See Figure 11 for the
visual representation of the data and Appendix II for the specific parameters. For
Advanced Bionics cochlear implants, the responses indicated the preference of always or
almost always in at least half of the responses for the following parameters: number of
active channels or electrodes, processing strategy (HiRes-P), pulse width, T Level, gain,
volume max, volume min, sensitivity, IDR, audio mixing, mic mode omnidirectional,
filter, and AGC. In Clearvoice off, a trend for deviating from the default settings was
found in the data. See Figures 12 and 13 for the visual representation of the preference
for Advanced Bionics default parameters and the preference for the Clearvoice default
setting respectively. Specific data for MAPping preferences was not collected for
Digisonic devices.
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Figure 10. Proportion of times the audiologists select the default parameters in implants
manufactured by Cochlear Corporation.
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Figure 11. Proportion of times the audiologists select the default parameters in implants
manufactured by MED-EL.
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Figure 12. Proportion of times the audiologists select the default parameters in implants
manufactured by Advanced Bionics.
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Proportion of audiologists using default clearvoice in Advanced
Bionics
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I never use
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Figure 13. Proportion of audiologists selecting the default setting for Advanced Bionic’s
clear voice algorithm.
Pediatric Follow-Up Clinical Measurements
At initial and follow-up MAPping visits for pediatric patients, 95% of the
respondents reported that they always measure electrode impedance. The remaining 5%
indicated that they almost always measure the electrode impedance. For measuring ECAP
(including NRT, NRI, and ART) in pediatric patients, 50% reported always taking these
measurements, 14% almost always measure ECAP, 27% estimated that they measure
ECAP approximately half of the time, and 9% reported sometimes measuring ECAP.
Measuring e-ABR was more divided, with 50% reporting sometimes taking these
measurements while 41% reported never measuring e-ABR. 5% reported measuring e-
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ABR about half of the time and an equal 5% reported almost always obtaining e-ABR in
their pediatric patients.
Pediatric ESRT (stapedial reflex) measurements were reportedly measured always
by 5% of the audiologists. The respondents reported that they measured ESRT almost
always (18%), half of the time (18%), and sometimes (27%). 32% of the audiologists
reported never measuring ESRT. Vestibular testing in pediatrics like ENG or VNG is not
as popular. 73% of the audiologists reported never obtaining this measurement in their
pediatric population. 5% reported almost always obtaining vestibular data and 23%
reported sometimes recording this information. See Figure 14 for the pediatric objective
measurements data.
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Figure 14. Frequency of performing objective measurements while programming
cochlear implants in pediatric population.
Adult Follow-Up Clinical Measurements
For the adult population, 95% of the audiologists reported always measuring
electrode impedance and 5% reported almost always obtaining this data. For ECAP
measurements, 32% reported always, 21% reported almost always, 11% half of the time,
32% sometimes, and 5% reported never taking these measurements in their adult patients.
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Similar to the pediatric data, e-ABR measurement was more split with 61% reporting
never obtaining this data, while 33% reported sometimes measuring e-ABR and 6%
reporting almost always running this test.
ESRT again reveals inconsistency in clinical practice with 5% reporting always,
11% almost always, 16% half of the time, 37% sometimes, and finally 32% reporting
never running ESRT in their adult cochlear implant recipients. Vestibular data was
reported as never being obtained by 74% of the responding audiologists. The remaining
21% reported sometimes collecting VNG or ENG data and 5% reported almost always
collecting this vestibular information. See Figure 15 for the adult objective measurement
frequencies.
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Figure 15. Frequency of performing objective measurements while programming
cochlear implants in adult population.

Bimodal Fitting Practices
Most Indian cochlear implant audiologists are recommending bimodal fitting for
their cochlear implant patients. 59% reported always recommending a hearing aid for the
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non-implanted ear in adult recipients. 32% recommended a contralateral hearing aid most
of the time and 9% recommended a hearing aid some of the time. For pediatrics, this
trend continues with 91% of audiologists always recommending a bimodal fitting, 5%
recommending a hearing aid in most cases, and 5% recommending a hearing aid about
half of the time (figure 16).

Bimodal Fitting Recommendation

Percentage of time
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91
Adult

80
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60
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40
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20
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0
Always

Most of the time About half the
time

Sometimes

Never

Figure 16. Bimodal fitting recommendation by cochlear implant audiologists in India.
Solid bars represent adult population and the hatched bars indicate pediatric population.

When choosing the prescriptive formula for a bimodal fitting regardless of the age
of the patient, 36% responded that they prefer the hearing aid manufacturer’s proprietary
formula, 29% recommended a NAL prescription, 29% use DSL, and 6% of the
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audiologists use their own gain prescription. Please note that this question did not ask for
preference in prescriptive formula for adults versus pediatrics. See Figure 17.

Figure 17. Audiologists’ preferred hearing aid prescription formula in bimodal fittings.
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Rehabilitation/ Habilitation Recommendations
For pediatric patients, 95% of the cochlear implant audiologists reported that they
always recommend speech therapy. The remaining 5% stated that they recommended
speech therapy most of the time for their pediatric population. Recommending
computerized auditory training yielded more divided results with 57% of the audiologists
never recommending this method of rehabilitation/ habilitation training. 10% always
recommend computerized audiologist training and the remaining 33% recommended it
once in a while for their pediatric patients.
Adult recommendations for rehabilitation / habilitation training differ greatly
from the pediatric recommendations. 57% of the respondents always recommended
speech therapy for their adult cochlear implant patients, and 5% recommended speech
therapy most of the time. 5% recommended adult speech therapy about half of the time,
19% reported making this recommendation once in a while, and 14% never
recommended speech therapy for their adult patients. Recommending computerized
auditory training in the adult population was again, split. Of the respondents, 42%
reported never recommending adult computerized auditory training, 11% reported always
recommending this training, another 11% recommended this most of the time, 16%
reported recommending computerized training about half of the time, and 21% reported
once in a while making this recommendation. See Figure 18 below for habilitation/
rehabilitation recommendations in the adult and pediatric populations.
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Figure 18. Frequency of speech therapy and computerized auditory training
recommendation by audiologists.
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Discussion
Jeyaraman (2013) surveyed pediatric cochlear implant centers and collected data
concerning how patients paid for their cochlear implants. The Jeyaraman (2013) survey
found that 52% of the patients were self-funded, 32% were funded by a government
assisted program, 11% were funding by a non-profit organization, and 5% were funded
by other charity organizations. Similarly, the present survey found that 40% of the
respondents indicated that their patients paid out of pocket. Another 40% indicated
government assistance programs aided their patients. 9% indicated that a private third
party health insurance funded the procedure and follow up. This option was not included
in the Jeyaraman (2013) survey. In the present survey, another 9% indicated that nonprofit or charity organizations helped their patients to cover the cost. 2% responded that
costs associated with the survey and follow up were unknown to them.
Preference for Default Parameters
Indian clinicians appear to follow the same patterns as was seen in the data
following clinical preferences in the U.S. by Browning et al. 2020. When MAPping
Cochlear and Med-El devices, there is a clear preference for the default parameters
established by the respective manufacturers. In most parameters of an Advanced Bionics
device, the same rings true; however, there is much more variety in the clinical MAPping
decisions of the processing strategy, which is currently HiRes-P, and the preference for
Clearvoice off.
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In the free response section, no respondents chose to elaborate why they choose to
change these two parameters when working with Advanced Bionics cochlear implants.
An interesting fact to note is that although HiRes-P is the default parameter in the
MAPping software for Advanced Bionics, the company recommends in its trainings to
switch the processing strategy to HiRes Optima P to significantly improve the battery life
of the processor. The company has not changed its default processing strategy since
HiRes P is the processing strategy used in the U.S. to gain FDA approval, not HiRes
Optima P.
Advanced Bionics is the only cochlear implant manufacturer out of the three that
does not recommend measuring T levels. In the initial FDA approval process, Clearvoice
was not an option in the software, so the default remains off. Since this process, this
parameter, when turned on has received a superior ranking, showing significant
improvements in speech clarity. As many findings in this data collection in India follows
the same observations as Browning et al. 2020, it may also be assumed that the thought
processes are the same between these two groups of professionals. In the Browning et al.
2020 paper, they also noted that clinicians mentioned changing these parameters based on
patient preference and issues with sound quality, which matches up with the information
showing Clearvoice on may alleviate these common complaints from patients.
Follow-Up Clinical Measurements
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Vestibular symptoms post cochlear implant operation can be as prevalent as 20%
according to a study conducted by Bittar, Sato, Ribeiro, & Tsuji in 2017. Despite the high
risk of dizziness in patients, 73% of the Indian audiologists surveyed in the present study
indicated that they never evaluate the vestibular system in their pediatric patients and
74% reported never assessing their adult patients.
While it was reportedly used more often than vestibular assessment, ESRT still
revealed a large variance in frequency amongst Indian clinicians. For the pediatric
population, the respondents indicated that they always (5%), almost always (18%), or
measured ESRT half of the time (18%) for their pediatric patients. This totals up to
clinicians regularly measuring ESRT in their pediatric population 41% of the time. For
adults, the Indian audiologists indicated always (5%), almost always (11%), and
measuring ESRT half of the time (16%). This adds up to 32% regularly utilizing this
objective measurement. These data are similar to the finding from Vaerenberg et al.
(2014) where they found that 39% of cochlear implant centers reported using eSRT as an
objective measurement in MAPping visits.
Vaerenberg et al. 2014 reported that 59% of their surveyed cochlear implant
centers used eCAP measurements when MAPping devices. In the present survey, 64% of
the Indian audiologists reported always or almost always measuring eCAP in their
pediatric population. For the adult population, 53% of the clinicians reported always or
almost always measuring eCAP. eCAP is clearly the more popular measurement;
however, the current data available comparing the two tests reveals that eSRT may be a

33

better predictor of MCL (Walkowiak et al. 2011). Additionally, time is valuable to any
working professional and Kosaner, Spitzer, Bayguzina, Gultekin, & Behar (2018) found
that measuring eCAP takes four times longer than measuring eSRT in cochlear implant
patients. Similar to the data from Browning et al. (2020), the current data reveals a
potential lag in implementing strategies in the modern research.

Bimodal Fitting Practices
Browning et al. 2020 hypothesized that if more pediatric cochlear implant
audiologists were surveyed in the U.S., there would be a higher preference for the DSL
prescriptive formula. In the current study, the question concerning the preference for
bimodal fitting formulae did not specify adult or pediatric patients. In the current study,
there was a much higher number of cochlear implants activated by the respondents for the
pediatric population, so it can be assumed that the respondents were answering in general
or leaning towards their clinical decisions for their pediatric patients. The results yielded
a fairly even preference between the manufacturer’s proprietary formula (36%), an NAL
prescription (29%), and DSL (29%). Only a small 6% answered that they use their own
gain prescription.
Regardless of prescriptive formula preference, most audiologists recommended a
bimodal fitting for their patients. 91% of the respondents stated that they recommended
bimodal fittings always or most of the time for their adult patients and 96% for the same
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in their pediatric patients. In the future, further clarification in this question could be
warranted to include asking if they would recommend a bimodal fitting if the patient was
a candidate. The current question did not specify this candidacy so there could have been
an unintended interpretation of this question.
Rehabilitation / Habilitation Recommendations
Jeyaraman (2013) mentions the large rural population of cochlear implant
recipients and candidates in India. This information coupled with the idea that India is not
considered to be a higher income country compared to the U.S. may help to interpret the
data revealing a lowered rate of computerized training for rehabilitation or habilitation
therapy in India. 57% of the respondents reported never recommending this method of
therapy for the pediatric population and 42% never recommended it for the adult
population.
57% of the audiologists always recommended speech therapy for their adult
recipients compared to 95% always recommended it for their pediatric patients. The
difference in frequency of this recommendation between the two populations could be
due to the fact that for most adult cases, it is assumed that rehabilitation would be the
case due to the fact that the adult would have likely acquired their hearing loss post
language acquisition. Since the adult patient likely already acquired speech before their
hearing loss progressed to the significance warranting a cochlear implant intervention,
they likely would not require speech therapy.
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When referencing the pediatric population and the modern recommendations for early
intervention, the cochlear implant is likely received prior or in conjunction with speech
and language acquisition; therefore, speech therapy would be integral for more rapid
success. Additionally, the Cochlear Group of India (2018) has set forth a “mandatory”
post-operative recommendation that the cochlear implant team must provide weekly
habilitation or rehabilitation plans for cochlear implant patients. Seeing as this
recommendation was set as a “mandatory” recommendation by this group, it is
interesting that not all practicing audiologists are recommending habilitation or
rehabilitation interventions.

Conclusion
In conclusion, the results of the present survey indicate that audiologists in India
have a clear preference for the default parameters as set for by the cochlear implant
manufacturers; however, there are exceptions where individual professionals may deviate
from these default settings. The audiologists responding to this survey clearly have varied
methods for working with their cochlear implant patients and these methods may not
follow the recommendations set forth by the Cochlear Implant Group of India (2018).
Similar to the findings by Browning et al. 2020, many audiologists in India do not always
use objective measurements in cochlear implant MAPping appointments. This could be
due to lack or access or lack of experience in their settings. In general, it does appear that
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these audiologists generally follow the same clinical practices and general
recommendations as one another. These generalized clinical practices that have some
variation backs the idea that clinicians adapt to each patient that comes through the door.
Future research should adapt to cultural considerations for each region analyzed and
should encourage more free response sections so that the clinical decision-making
process may be better understood when a deviation from the default is found. Information
collected in the present survey is not intended to be used to create standardized best
practices in India or elsewhere. The information collected is intended to be used to create
a better understanding of current clinical practices to improve future cochlear implant
clinical outcomes for our patients.
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Appendix I: Literature Review
Hearing loss is a medical condition that affects millions of people around the
globe. The most recent data published by the World Health Organization (WHO) in 2018
estimates that approximately 466 million people are currently living with significant
hearing loss, enough to interfere with these people’s quality of life and daily living. In
2018, this equated to approximately 6.1% of the global population and is only expected to
grow as the advances in healthcare expands the expected lifespan. In fact, WHO
estimates that by 2050, over 900 million people will be living with disabling hearing loss
(World Health Organization, 2018).
As the number of people with hearing loss rises, it increases disproportionally
around the world. For example, by 2050, WHO estimates that approximately 72 million
citizens from high income areas like the United States, Western Europe, and Australia
will have significant hearing loss compared to 267 million citizens in South Asia. With
such substantial projections like these, it is imperative that research is conducted on the
current practices to combat this condition in all emerging markets, not only those in
higher income countries.
The World Health Organization (2017) also published a report addressing the
economic impact of unaddressed hearing loss. This economic impact is not limited to the
cost of an amplification device and related services; this impact also addresses other life
consequences of significant hearing loss. When hearing loss is unaddressed, it can have
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negative impacts on communication with others (Ciorba, Bianchini, Pelucchi, & Pastore,
2012), language acquisition (Yoshinaga, Sedey., Coulter, & Mehl, 1998), academic
achievement (Tharpe, 2008), and job opportunities (Jung & Bhattacharyya, 2012). All of
these potential negative impacts can also lead to feelings of isolation, depression, and
cognitive decline (Arlinger, 2003).
This economic report focuses on the impacts of a significant hearing loss defined
as at least a moderate degree of hearing loss. Globally, it is estimated that in 2015, the
economic impact of significant hearing loss to the healthcare sector was approximately
$67-107 billion dollars, $3.9 billion dollars for the educational sector, $105 billion loss in
the job market, and $573 billion lost in societal costs as a result of social isolation,
communication problems, and social stigma. Altogether, this is an estimated $750-790
billion-dollar annual loss globally. An estimated 63% to 73% of this loss in the
healthcare and educational sectors come from low- and middle-income countries. This
may be because the larger availability of medical and healthcare solutions tends occurs in
higher income countries, so there are higher rates of interventions that may decrease this
loss. Furthermore, this report continues on to state that cochlear implants are undoubtedly
the most cost-effective solution for addressing the economic impact that hearing loss has
globally. In fact, the cost of the cochlear implant and associated services are significantly
less than letting the hearing loss go untreated (World Health Organization, 2017).
Patients of any age can have significant hearing loss. In fact, of those who are
affected by disabling hearing loss, WHO estimates that 93% are adults and 7% are
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children (World Health Organization, 2018). Even though more adults are potential
cochlear implant candidates than the pediatric population, many financial assistance
programs may focus on the pediatric population as the consequences of auditory
deprivation for this population may be more costly than the financial impact of the unaided adults (World Health Organization, 2017).
Although many factors may increase the risk of hearing loss such as age,
occupation, genetics, overall health, etc., hearing loss can affect anyone. In the last
centennial, nearly all markets have seen a surge in technological advances, especially in
healthcare. The field of audiology is no different and has been attempting to discover
innovative solutions to address hearing loss. One of the solutions for the most significant
of hearing losses is the cochlear implant device.
A cochlear implant is a medical device which transforms soundwaves into
electrical signals that directly stimulate the auditory nerve for the brain to interpret
(Waltzman & Roland, 2014). These devices must be custom programmed to the
individual with regular follow up visits with a cochlear implant professional for best
outcomes (Vaerenberg et al., 2014). Regular follow up programming visits are integral to
the success of the patient as Hughes et al. (2001) points out that the minimum current
levels increase over the first year following implantation for the pediatric population and
the maximum current levels increase over the same time period for both the adult and
pediatric cochlear implant population. By carefully programming these devices, the
patient may see large improvement in their speech understanding. Traditionally, prior to
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implantation, these patients yield poor word understanding and the intention of receiving
a cochlear implant is to replace the low or non-functioning auditory abilities with a new
way of interpreting auditory stimulus (Waltzman & Roland, 2014).
A normal auditory system transfers sound energy into mechanical energy which is
lastly transferred into electrical energy that the auditory nerve sends to the brain to
interpret. To understand how the cochlear implant works, it is important to first
understand an intact system and how it transfers this sound energy. Following the transfer
of energy, soundwaves which travel through the air make their way into the s-shaped
outer ear canal, hit the tympanic membrane, otherwise known as the eardrum. When the
tympanic membrane moves due to the vibration of the soundwaves, this initiates the
ossicles, the three tiny bones in the middle ear which are attached to the tympanic
membrane to move in tandem. The final of the three ossicles, the stapes, is attached to the
oval window of the cochlea, otherwise known as the hearing organ (Wilson & Dorman,
2008). The cochlea is innervated by the VIIIth cranial nerve, otherwise known as the
auditory nerve.
The cochlea is the most complex of all the sensory organs in the human body and
is vital for auditory input and processing. Located in the petrous portion of the temporal
bone, the cochlea is often discussed in one of two perspectives. The first perspective
views the cochlea as it sits in the skull, wrapped up like a snail shell around a bony axis
called the modiolus. In the second perspective, the cochlea is discussed uncoiled. In
humans, the cochlea has around 2.5 turns as it spirals around the 5mm tall modiolus.

41

When unrolled, the cochlea is around 30-40mm long. The cochlea is made up of two
labyrinths: the osseous (bony) labyrinth and the membranous labyrinth (Nie, 2018).
The osseous labyrinth is composed of bony structures, while most of the cochlear
contents reside in the membranous labyrinth. The membranous labyrinth contains three
fluid filled compartments: the scala vestibuli, the scala tympani, and the scala media. The
scala vestibuli and the scala tympani are connected at an area of the osseous labyrinth
called the helicotrema (Moller, 2006). The scala media, also known as the cochlear duct,
is separated by Reissner’s membrane superiorly and the basilar membrane inferiorly
(Seikel, Konstantopoulos, & Drumright, 2018).
The organ of Corti resides on the basilar membrane and contains the inner and
outer sensory hair cells of the cochlea (Seikel et al., 2018). The basilar membrane is the
widest and thickest at its base and becomes narrower and thinner as it continues to the
end of the apex. The basilar membrane is arranged in a log-linear pattern tonotopically. In
other words, each frequency within the normal human hearing range has a specific place
on the basilar membrane where the membrane reaches its maximum displacement, also
referred to as the resonant frequency. As sound enters the cochlear system via the
vibration of the oval window, the fluid displaces the basilar membrane and triggers the
hair cells to release neurotransmitters, which triggers the electrical impulses for the
auditory nerve (Nie, 2018).
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The cochlear implant is one of the most successful medical inventions of all time.
The cochlear implant device is made up of an internal component and an external
component. The internal component consists of an internal receiver with an electrode
array which is inserted into the scala tympani in the cochlea (Zwolan, 2008). When
different electrodes are activated by varying degrees of electrical current, they stimulate
tonotopic neurons of the auditory nerve. This stimulation creates a signal for the brain to
interpret as an auditory signal, and in the optimal situation, the patient perceives and
understands this signal similarly to how most people interpret natural soundwaves
(Wilson & Dorman, 2008). The idea behind the electrode array is to match up as much as
possible with the tonotopic organization of the basilar membrane. The multiple electrode
stimulation should improve the place-frequency information that the brain was previously
lacking to adequately separate (Saleh et al., 2013).
Following the surgery where the internal component is implanted into the patient,
the external cochlear implant device is fit, otherwise known as programmed, to the
patient’s specific needs. This external component is what picks up natural soundwaves,
processes this signal, and sends this signal to the internal component to be transformed
into electrical impulses for the internal component to receive and continue the signal
transfer to the auditory neurons (Wilson & Dorman, 2008). The fitting process begins
approximately one month after the surgery to ensure that the incision area and surgical
area have healed, and the swelling has reduced as to not interfere with patient comfort or
the connectivity of the two device components (Vaerenberg et al., 2014). Vaerenberg et
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al. (2014) international survey results confirm that on average, cochlear implant centers
wait the average one-month period after surgery to begin the audiologic care.
At first fit, the cochlear implant manufacturers recommend that impedance
measures are taken to ensure the integrity of the electrodes in the internal component’s
electrode array. If any of the electrodes are flagged as having a problem, those electrodes,
and typically the adjacent electrodes are deactivated in the software (Vaerenberg et al.,
2014). After the impedance measures are complete, most programming professionals
move on to measuring the minimum (referred to as T Levels or THR) and maximum
current levels (referred to as C Levels, M Levels, or MCL) for the electrical signals from
the cochlear implant. The process to setting these levels differs amongst cochlear implant
manufacturers (Wolfe & Schafer, 2014).
Obtaining the minimum and maximum current levels can be done with objective,
subjective, or both types of measures. Sound booth testing is not typically performed at
the cochlear implant fitting appointment according to Vaerenberg et al. (2014). Follow up
programming appointments generally consist of programming the minimum and
maximum current levels until they become stable for the patient as well as booth testing
to document patient progression with the cochlear implant in terms of auditory perception
and understanding. Any cochlear implant programming is saved as a MAP. A MAP
simply refers to a saved cochlear implant program or parameters (Wolfe & Schafer,
2014).
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According to Kumar & Kameswaran (2017), an estimated 63 million Indian
citizens live with severe to profound hearing loss. This means that approximately 63
million Indians are potentially eligible for a cochlear implant according to the guidelines
set forth by The Cochlear Implant Group of India (2018). With ever growing numbers,
India is growing with the trend. As of 2017, the country contained approximately 200
cochlear implant centers and had developed The Cochlear Implant Group of India, which
provides guidance for cochlear implantation practices in the country. Additionally, by
2017, the country had seen over 25,000 cochlear implantations (Kumar & Kameswaran,
2017).
The emerging market in India is not isolated. In fact, upon such successful
program implementation, surrounding countries such as Nepal, Sri Lanka, and
Bangladesh have collaborated with the Indian government to employ similar government
programs within their borders (Kumar & Kameswaran, 2017). High success and heavy
influence on the world market make India a great area of interest in modern cochlear
implant device fit and follow up methodology.
As the popularity of cochlear implants increases, as does the need for
standardized care. The Cochlear Implant Group of India has published their
recommended guidelines for clinical practice; however, these are guidelines rather than
true, binding requirements for professionals who work with these devices (The Cochlear
Implant Group of India, 2018). While this is a great starting point, to the knowledge of
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the authors of this paper, there is no published data exhibiting if Indian professionals are
following these recommendations in their practices.
Vaerenberg et al. (2014) published some of the first information about
international cochlear implant trends. This study sent a survey to 47 international
cochlear implant centers to find out about the current clinical trends in the fit and follow
up of cochlear implant patients. These centers spanned a total of 17 different countries.
Amazingly, all of these cochlear implant centers participated in this survey. The study
also invited the participants to provide further, more specific information where the
researchers followed the fitting process for five actual patients at each center. A total of
34 of the centers participated in the follow up cochlear implant fitting data collection.
The survey focused on five main areas: number of patients and the projected patient
growth, cochlear implant brands used, MAP parameters used, assessments used for
performance and programming, and targets used.
While Vaerenberg et al. (2014) collected some of the first international data about
clinical cochlear implant strategies, this research was skewed towards the European
practices and may be lacking in the larger global perspective. This is especially
imperative to understand as the WHO data has identified other emerging global giants in
terms of growing markets and regions with high numbers of significant deafness that
could be described as more of the developing world rather than higher income countries
(World Health Organization, 2018).
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The Vaerenberg et al. (2014) study also found that certain countries tended to be
outliers in terms of their methods and protocols compared to the rest of the survey
respondents. For example, the Mumbai cochlear implant center, which is located in India,
reported that they tend to see their patients for follow up appointments after the first year
only at the patient’s request while the common trend for the majority of the other centers
surveyed revealed that their standard protocol was to see their cochlear implant recipients
on a minimum of an annual basis following the first year. As the current study is
evaluating the clinical practices in India, this was a particularly interesting finding within
the Vaerenberg et al. (2014) survey.
Similar to Vaerenberg et al. (2014) survey, Jeyaraman (2013) also sent out a
survey specifically looking at general cochlear implant practices and habilitation
programs, but this survey focused solely on cochlear implant centers within India. The
survey was sent to 35 Indian cochlear implant centers and had a 63% response rate. Since
the focus was more on habilitation services, the questions mostly implied the practices
used for pediatric patients. This survey found that nearly half of the programs advised a
program lasting longer than a year while the other half advised a year of habilitation
services.
Prior to the implementation of governmental assistance programs for cochlear
implant recipients, including the pediatric population, most Indians had to cover the cost
of the cochlear implant and the subsequent care. This made cost a major concern and
possible deterrent for treatment for significant hearing loss in the country. This may be
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one of the main contributing factors as to why the public was slow to adopt cochlear
implantation as a common practice in India when looking at the growth since the first
availability of these devices in the country (Jeyaraman, 2013). Another known factor was
social constraints as many communities were not quick to adapt to the new technology
(Kumar & Kameswaran, 2017).
Jeyaraman (2013) reports that one such government assistance program in India
covers the funding for the cochlear implant surgery and habilitation program for pediatric
patients 12 years of age and younger. Other programs may cover partial cost or have a
limit to what services or costs are covered. In the Jeyaraman (2013) survey, they found
that the pediatric cochlear implant centers were reporting approximately 52% of the
patients were self-funded, 32% were funded by a government assistance program, 11%
were funded by nonprofit organizations, and 5% were funded by other charities.
The term habilitation is in reference to the pediatric population where these
patients will be acquiring oral-aural language with their cochlear implant. The term
rehabilitation is in reference to the adult or at the very least, the post-lingual population
where these patients will be aiming to have greater benefit in the already acquired oralaural cues from an earlier time in the patients’ lives. Since the first cochlear implant
approval in 1985, candidacy requirements in the U.S. and around the world have
expanded to include both the pre and post lingual patients, which in turn also expands the
potential habilitation and rehabilitation strategies used in the follow up care of cochlear
implant patients (Carlson et al. 2018).
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Jeyaraman (2013) also found that in Indian habilitation programs, the
professionals involved on the habilitation cochlear implant teams were as follows:
audiologists and speech pathologists (43%), special educators (25%), trained nonprofessionals (19%), specialists with diplomas/ certifications in hearing instruments
(9%), social workers (2%), and otolaryngologists (2%). The study also found that 68.2%
of the surveyed centers required the pediatric patients to try amplification for 3-6 months
before implantation, which is particularly interesting as the recommendations from The
Cochlear Implant Group of India were published at this time which suggested that
amplification with auditory based intervention had to be implemented for at least 3
months before the decision for surgery (Jeyaraman, 2013; The Cochlear Implant Group
of India, 2018). Additionally, many of the centers were developed under the guidance of
this group. It is unclear if the remaining 31.8% of the centers required more or less time
with alternative amplification prior to cochlear implantation (Jeyaraman, 2013). This
survey summarized its findings by emphasizing the need for a standardized service
delivery model that would best fit the needs of India. As this does not currently exist, a
good starting place may be finding out the common clinical trends currently in practice.
As mentioned above, India is not the only country who lacks true, evidence-based
binding requirements for the standardized care of cochlear implants. Virtually all
countries regularly fitting cochlear implants have developed groups who make
recommendations towards the goal of a standardized care but based on the trends
reported in surveys like the Vaerenberg et al. (2014) survey and the Jeyaraman (2013)
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survey, these recommendations have not necessarily been implemented in widespread
practice. Browning et al. (2020) completed a comprehensive survey to track these trends
in the United States. Their study and its questionnaire were based off of the Vaerenberg
et al. (2014) survey and also included data collection for areas like clinical setting,
bimodal fitting, and specific evaluations used to drive programming and document
performance.
Bimodal fitting refers to patients who wear a cochlear implant on one ear and a
hearing aid on the opposite ear. Some hearing aids are specifically designed to operate
with cochlear implants in terms of inter-ear communications. For example, if a patient
wears a ReSound brand hearing aid on one ear and a Cochlear brand cochlear implant on
the opposite ear, these devices can be paired and work together for sound processing and
streaming. If a patient has a hearing aid not designed for their cochlear implant device,
the two devices can still be worn. In this case, the devices must be treated and cared for
as two completely independent devices (Wolfe & Schafer, 2014).
Scherf et al. (2014) published an international survey where they collected
international fitting data specifically evaluating bimodal fitting practices. They emphasize
that bimodal fittings should be considered standard practice since the binaural benefits
provided by this type of fitting are well documented in the modern literature. These
benefits include but are not limited to improvements in speech perception in noise,
improved localization, and improved sound and music quality. In the earlier days of
cochlear implantation, a common worry was that having the mismatched technology in a
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bimodal fitting could lower overall performance and the performance of the cochlear
implant (Scherf et al. 2014). Messersmith, Jorgensen, & Hagg, (2015) quote research
suggesting that lowered performance with a bimodal fitting versus the cochlear implant
alone is more suggestive of an inappropriate bimodal candidate. This result is more
indicative that the patient is a bilateral cochlear implant candidate.
Ching, Incerti, & Hill (2004) disputed this theory when they found significant
binaural benefits in their experiments namely in the realms of speech understanding,
horizontal localization, and real-life functional performance in patients who were fit
bimodally. These benefits were discovered in users who had been wearing both their
cochlear implant and hearing aid for more than five years and in new users who had only
had their hearing aid for eight weeks prior to testing. Based on the results of this study,
they also suggested that bimodal fittings become the standard in situations of unilateral
cochlear implantation (Ching et al., 2004).
In the situation where a patient has lower speech perception performance when fit
bimodally and a second cochlear implant is not an option, Messersmith et al. (2015) offer
some potential solutions for hearing aid programming where the patient may see an
improvement. Factors where a patient may not be a bilateral cochlear implant candidate
even if their speech perception scores suggest otherwise include but are not limited to
health status of the patient, surgical considerations, and cost of a second implant and
related services. Rather than forego the hearing aid right away, Messersmith et al. (2015)
suggests modified the frequency response of the hearing aid by 1) manipulating gains
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across all frequencies, usually the high frequencies or 2) through the use of frequency
lowering algorithms provided by the hearing aid manufacturer’s software. Caution should
be taken on these approaches as research conducted on the outcomes associated with
these programming changes have been mixed.
Ultimately, the results in the Messersmith et al. (2015) study found that their
bimodal fitting procedure was not a one size fit all solution and called for more complex
research on this subject that takes into consideration bilateral cochlear implant candidacy,
cochlear dead regions, and neural atrophy following auditory deprivation. Another
conflicting finding in the research surrounding bimodal fitting practices is that of the
recommended fitting formula. Messersmith et al. (2015) and Yehudai et al. (2013)
suggest more emphasis in the low frequencies may improve speech performance for the
bimodal patient; however, Siburt and Holmes (2015) surveyed 93 cochlear implant
centers and the majority reported using NAL formulas, which instead, increases high
frequency gain.
The Scherf et al. (2014) survey investigated common trends in modern bimodal
fitting practices internationally. This survey sought answers for seven areas: profile,
general information, bimodal counseling, patient feedback, the bimodal fitting process,
bimodal evaluation, and the projected bimodal future. 65 clinicians responded to the
survey from 12 countries. The results indicated that in the adult unilateral cochlear
implant population, 32% were bimodal users compared to 26% in the unilaterally
implanted pediatric population. All respondents indicated that they would recommend a
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bimodal fitting if the patient was a candidate. For 65% of respondents, the bimodal
services were performed at the same facility rather than have the patient have different
service providers. There was no general consensus for the bimodal candidacy criteria
besides the patient having aidable hearing in the contralateral ear. One common factor
that was reported for patients choosing to not go down the bimodal route was the cost of
the hearing aid.
The recommendations for when to begin the hearing aid fitting varied amongst the
clinicians with 58% recommending fitting the hearing aid at the cochlear implant
activation while another 25% recommended that the hearing aid be fitted at least a month
after the cochlear implant activation. Another trend included that 77% of clinicians
recommended part-time use of the hearing aid compared to 13% who recommended full
time use. During the hearing aid fitting appointment, 86% of respondents reported that
they would turn off the cochlear implant device. Common hearing aid fitting methods
included no gain for the high frequencies, subjective hearing aid balancing, fitting the
hearing aid and the cochlear implant independently of one another, and trial and error
type approaches. Many clinicians reported that they would leave the hearing aid
programming as is before the cochlear implant activation. One important note about this
survey is that the data may be skewed since 35% of the respondents were from Belgium
(Scherf et al., 2014).
Shapiro and Bradham (2012) credit the success of the cochlear implant user
largely to the audiologist MAPping the device. This makes evaluating the practices of
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these clinicians even more imperative to the ultimate goal of creating national or even
global standardized fitting and follow up practices. The Browning et al. (2020) survey
had a 70% response rate after sending their survey to self-identified cochlear implant
audiologists across the United States. This study also addressed how national
organizations like the American Speech Language Hearing Association and the American
Academy of Audiology provide cochlear implant clinical practice recommendations,
similar to those provided by The Cochlear Group of India, but again, these are nonbinding recommendations and may possibly be lacking true researched evidence to
support all of the recommendations (Sorkin et al. 2013).
The Browning et al. (2020) survey collected data for the following areas: work
setting, number of pediatric and adult cochlear implants activated by the survey
respondent, additional cochlear implant related services offered, which manufacturer is
used, the frequency of use of default manufacturer settings for each manufacturer, use of
objective measures during programming, use of subjective measures during
programming, bimodal fitting practices, and habilitation/ rehabilitation practices. Overall,
this survey did not find a correlation between experience and practical application of
techniques. This study did find that preference for default manufacturer settings was
largely dependent on the manufacturer of the cochlear implant device, similar to the
findings in the international survey completed by Vaerenberg et al. (2014).
The Browning et al. (2020) survey also found that in the United States, objective
programming practices were practically the same regardless of the age of the patient.
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There was a difference in what objective measurers were used: most measured
impedances, 42% for adult patients and 62% for pediatric patients regularly measured
electrically evoked compound action potentials (eCAP), and less than 20% measured
electrically evoked auditory brainstem response (eABR), electrically-evoked stapedial
reflex threshold (eSRT), or vestibular assessments. The pros and cons of the different
objective tests may influence why some are used over others. For example, Kosaner,
Spitzer, Bayguzina, Gultekin, & Behar (2018) found that eSRT takes four times as long
to measure in the appointment than eCAP; however, Walkowiak et al. (2011) reports that
for predicting MCL, eSRT outperforms eCAP. For most clinicians time is extremely
valuable and must be considered along with best patient practices, which may account for
the disparity in clinical practices found in the Browning et al. (2020) survey results.
As far as subjective measurements, this survey found that practices may be
dependent on the selected manufacturer. T levels were almost always measured for
Cochlear devices but decreased in usage for Med-El and Advanced Bionics as the
software for these two manufacturers have the capability of predicting these values based
on other measurements. Other subjective measure findings included that 56% of
respondents reported regularly using loudness balancing techniques and only 16%
regularly measured pitch ranking between electrodes. It is interesting to note that Saleh et
al. (2013) reports that the method of pitch ranking electrodes is known to improve speech
perception scores, yet this is a measure infrequently evaluated by the clinicians
responding to this survey.
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The large majority, specifically 75% of the respondents, tend to recommend
bimodal fitting for their cochlear implant patients. An interesting finding is that many
participants are more likely to recommend a bimodal fitting after the patient has worn
only the cochlear implant for a period of time. This differs from the research done by
(Scherf et al. 2014), who encourages minimizing the risk of auditory deprivation for both
ears. This again emphasizes the point that although trends and recommendations exist,
they may not align with the modern research for true evidence-based practice. The
respondents also clarified the situations where they would likely not recommend a
bimodal fitting. These included if the patient was a binaural cochlear implant candidate,
if the patient was not motivated for contralateral amplification, and if auditory
performance decreased with auditory stimulation on the contralateral side (Browning et
al., 2020).
For fitting a hearing aid for bimodal listening, the fitting formula typically used
varied amongst participants. 40% reported that they preferred the National Acoustic
Laboratories (NAL) fitting formulas, 25% reported preference for Desired Sensation
Level (DSL) or the manufacturer proprietary fitting formula. Please note that similar to
research (Ching et al. 2010) suggesting DSL fitting formula usage for the pediatric
hearing aid population, United States cochlear implant audiologists tend to prefer this
fitting formula for their pediatric cochlear implant patients as well. As far as preferred
hearing aid manufacturer for a bimodal fitting, 81% of audiologists prefer recommending
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the hearing aid manufacturer that has partnered with the cochlear implant manufacturer
for inter-device communication possibilities (Browning et al., 2020).
One of the only findings where practices differed between the adult cochlear
implant population and the pediatric population was in terms of habilitation/
rehabilitation recommendations. 100% of respondents recommend speech therapy for
pediatric patients compared to the mere 26% who recommend speech therapy for adults
(Browning et al., 2020). This may simply be due to the fact that it is assumed that most of
the pediatric population receive a cochlear implant for language development while the
majority of the adult population is assumed to have developed language prior to cochlear
implantation. On the reverse, 52% of United States participating audiologists recommend
computer based listening programs for their adult patients compared to only 30% making
the same recommendation for their pediatric patients (Browning et al., 2020).
While discussing the results, Browning et al. (2020), makes an excellent
observation that in the United States, manufacturer defaults must be approved prior to
using them, especially for the pediatric population. This means that there may be
different defaults and settings available in other countries, like India. Additionally, there
are four cochlear implant manufacturers available in India compared to the United States,
the fourth addition being Digisonic (Vaerenberg et al. 2014).
Another area where clinical practice in the Browning et al. (2020) study differs
from the current research suggestions include the use of vestibular objective measures.
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Bittar, Sato, Ribeiro, & Tsuji (2017) reports the incidence of dizziness following the
cochlear implant surgery to be upwards of 20%. Despite this high incidence, United
States audiologists are reporting infrequent vestibular assessments for these patients in
everyday practice. It is also interesting to note the large number of clinicians who use any
hearing aid formula besides an NAL fitting formula as Ching et al. (2004) is still to this
day one of the only studies providing true evidence-based recommendations for bimodal
fitting. This study specifically outlines the fitting protocols used during experimentation
and gave direct measures of binaural benefits and increased speech perception
performance while matching NAL targets.
The Cochlear Implant Group of India (2018) sets forth the following audiological
testing and results recommendations that will be explored in this survey and discussion.
This first section will explore the tests and results which the Cochlear Implant Group of
India lists as being mandatory in their recommendations. In regard to both objective and
behavioral testing, severity of hearing loss which would make a patient a candidate for
cochlear implantation includes severe to profound hearing loss, moderately severe to
profound hearing loss, bilateral moderately severe to profound hearing loss, and these
hearing losses should be accompanied by a Type A or As tympanogram with absent
reflexes. These hearing losses should present on one or more of the following behavioral
tests: behavioral observation, visual reinforcement audiometry, sound field testing, pure
tone audiometry, and immittance test battery for the tympanogram and reflexes. When
behavioral testing is not an option or results are unreliable, an auditory brainstem
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response (ABR) test using clicks with rarefaction and condensation as well as 500 Hz and
1000 Hz tone bursts should show absent bilateral wave V at 90 dB nHL. For otoacoustic
emissions (OAEs), including screening and diagnostic OAEs, these OAEs should be
absent and repeated after 15 days for infants. Finally, if the above criteria are met, the
patient should receive little or no benefit when fitted with hearing aids on the aided
audiogram, speech perception tests, and auditory/speech therapy progress reports after at
least 3 months of wearing the hearing aids.
The next test is instead listed by The Cochlear Group of India as recommended
instead of mandatory recommendations. Use of the auditory steady state response testing
(ASSR) is indicated when no wave V is present on the ABR. Finally, the group lists the
next set of tests as optional in their recommendations. Trans tympanic electrically evoked
brainstem response test, cortical testing, late latency response (LLR) test, and the middle
latency response (MLR) test may be used when there is indication that cochlear nerve
hypoplasia or aplasia or auditory neuropathy spectrum disorder (ANSD). Speech and
language evaluations are also optional in the group’s recommendations for standard preoperative cochlear implant practices.
For post-operative care as it relates to the relevant cochlear implant programming
and habilitation/ rehabilitation to this study, for both pediatrics and adults, The Cochlear
Implant Group has listed that it is mandatory to obtain a cochlear implant aided
audiogram to ensure proper MAPping and that weekly habilitation/ rehabilitation plans
must be enacted. For adults, the aided testing must also include speech perception testing.

59

Under recommended practices, the group lists that standardized speech perception tests
must be developed for all regional languages, which implies that these tests do not
currently exist (The Cochlear Implant Group of India, 2018).
Interestingly, the above information from the recommendations from The
Cochlear Implant Group of India is as comprehensive as the recommendations are in
relation to audiologic services that will be covered in the present survey. The
recommendations do not list any more specifics about cochlear implant MAPping,
amount of follow up adjustments and testing, or methods relating to the audiologic
services during the follow up appointments. This continues to leave an absence in the
knowledge of clinical application and methodology of cochlear implant fitting and follow
up practices.
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Appendix II: A Survey of Cochlear Implant Clinical Protocols
Hello: We appreciate your willingness to participate in this survey about cochlear implant
clinical protocols in your clinic. This survey is being administered by researchers from
James Madison University. Your participation in this survey is completely voluntary and
your answers will be completely anonymous. The survey is expected to take
approximately 30 minutes of your time. When considering the following questions,
Please think of your cochlear implant programming practices in general and what testing
and programming you usually perform.
Definitions: Adult: Patients age 18 years and older; Pediatric: Patients below 18 years of
age; Mapping visits: Mapping visits refer to the visits when at least a new MAP is
measured, and the sound processor is configured and programmed (with either an old or
new MAP).
Please answer the following questions about your own clinical setting
Please identify your role in the cochlear implant team:
1.

Audiologist

2.

Otolaryngologist (ENT specialist)

3.

Other professional
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Since you began programming cochlear implants, about how many ADULT cochlear
implants have you, personally, activated?

Since you began programming cochlear implants, about how many PEDIATRIC cochlear
implants have you, personally, activated?
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What best describes your clinical setting? (Select all that apply)
1.

Privately owned Audiology clinic

2.

Medical College Hospital

3.

Audiology clinic at an institute offering degree program/s in Audiology

4.

Audiologist working in an Otolaryngologist’s practice

5.

Other setting

Types of Services provided at your workplace: Please indicate which services are
provided at the facility in which you work.
Medical/ENT
1.

Yes

2.

Referred elsewhere
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Surgical (cochlear implantation)
1.

Yes

2.

Referred elsewhere

Auditory rehabilitation / Speech Language Therapy
1.

Yes

2.

Referred elsewhere

Hearing aid fitting
1.

Yes

2.

Referred elsewhere

Vestibular assessment
1.

Yes

2.

Referred elsewhere

Psychological evaluation
1.

Yes

2.

Referred elsewhere
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Other (please explain)

How is the cost of cochlear implantation covered at your clinic/institution/hospital?
(Select all that apply)
1.

Patient pays the cost of device and surgery from their own pocket

2.

A private third party (health insurance) pays majority of the cost

3.

The patient receives the cochlear implant free (or subsidized) cost through a

Government of India or State Government scheme.
4.

Other means (e.g. international aid groups)
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5.

Unknown

If your clinic/institution/hospital participates in a Government of India or state
government scheme, approximately what proportion of patients receive free/subsidized
cochlear implants?
1.

All of our patients receive CI through ADIP scheme

2.

Between 76% - 100% of patients

3.

Between 51% - 75% of patients

4.

Between 25% - 50% of patients

5.

Less than 25% of patients

Please answer the following questions about the process of selecting cochlear implants
for your patients
How is the decision made about which Cochlear Implant manufacturer to use?
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Alway Most

About

Somet

s

of the

half

imes

time

the

Never

N/A

time

Surgeon preference

❏

❏

❏

❏

❏

❏

Audiologist

❏

❏

❏

❏

❏

❏

Patient preference

❏

❏

❏

❏

❏

❏

Only one CI manufacturer

❏

❏

❏

❏

❏

❏

recommendation

available at my clinic
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Which Cochlear implant manufacturers do you work with in your clinic?
1.

Cochlear

2.

Advanced Bionics

3.

MED-EL

4.

Digisonic

5.

Other indigenously developed cochlear implants (please elaborate in the text box

below)
Please provide any additional information about other cochlear implant manufacturers
used in your clinic (manufacturer name)
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Pre-implantation counselling: which clinical professionals are involved in counselling the
patient and their family prior to the cochlear implantation? (check all that apply)
1.

ENT surgeon

2.

Audiologist

3.

Psychologist

4.

Speech Language Pathologist

5.

Other professional

How frequently are patients implanted off-label? (Off-label refers to a case where the
patient does not satisfy all the CI candidacy criteria, but the surgeon feels a medical
necessity to perform cochlear implantation) Please enter your answer in the text box
below (e.g. less than xx% cases)
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The following questions are about mapping Cochlear devices.
Do you work with Cochlear devices?
1.

Yes

2.

No

Which of the following services you provide for Cochlear patients?
1.

Pre-implantation counseling

2.

Mapping

3.

Troubleshooting

70

4.

Follow up mapping / fine tuning

5.

Aural rehabilitation

6.

Other __________

When mapping Cochlear devices how often do you select the default settings for the
following parameters?

Number of active

I always Almost

Half the Someti

I never

use

Time

use

Always

mes

default

default

setting

setting

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

channels/electrodes

Gain (default=0)
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❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

Channel Rate (default 900)

❏

❏

❏

❏

❏

Maxima (default is 8)

❏

❏

❏

❏

❏

Pulse Width (25)

❏

❏

❏

❏

❏

Volume Adjustment (20% of

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

Processing Strategy (default is
ACE)

Stimulation Mode (default is
MP1+2)

Dynamic Range)

Analysis of C-SPL (65)
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Analysis of T-SPL (25)

❏

❏

❏

❏

❏

Loudness Growth (20)

❏

❏

❏

❏

❏

Frequency Table

❏

❏

❏

❏

❏

Power (auto)

❏

❏

❏

❏

❏

Volume and Sensitivity (Volume

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

is 6, sensitivity is 12)

Program Settings (default is
SCAN)

If you do not use the default settings for any of the parameters, what value (or range of
values) you typically use? Please enter in the text boxes below. If it is not applicable,
leave the boxes empty and move to the next question.
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Enter

What is your

alternate

reason for

values in the using
boxes

alternate

below.

values?

Number of active channels/electrodes

❏

❏

Gain (default=0)

❏

❏

Processing Strategy (default is ACE)

❏

❏

Stimulation Mode (default is MP1+2)

❏

❏

Channel Rate (default 900)

❏

❏
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Maxima (default is 8)

❏

❏

Pulse Width (25)

❏

❏

Volume Adjustment (20% of Dynamic Range)

❏

❏

Analysis of C-SPL (65)

❏

❏

Analysis of T-SPL (25)

❏

❏

Loudness Growth (20)

❏

❏

Frequency Table

❏

❏

Power (auto)

❏

❏
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Volume and Sensitivity (Volume is 6, sensitivity is

❏

❏

❏

❏

12)

Program Settings (default is SCAN)

The following questions are about mapping Advanced Bionics devices.
Do you map Advanced Bionics devices?
1.

Yes

2.

No

Which of the following services do you provide for Advanced Bionics patients?
1.

Pre-implant counseling

2.

Mapping

3.

Troubleshooting

4.

Follow up/fine tuning

5.

Aural rehabilitation
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6.

Other

When mapping Advanced Bionics, what percentage of the time do you use HiRes
Optima P vs. HiRes Optima S strategies?

Enter your
answer in %
below. Both
should add up
to 100%.

HiRes Optima P

❏

HiRes Optima S

❏

When mapping Advanced Bionics devices how often do you select the default settings
for the following parameters?
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I always Almost

Half the Someti

I never

use

time

use

always

mes

default

default

settings

settings

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

Clearvoice (default is “Off”)

❏

❏

❏

❏

❏

Pulse Width (default is APW I)

❏

❏

❏

❏

❏

T Level (default is 10% of M)

❏

❏

❏

❏

❏

Gain (default is 0 for all channels) ❏

❏

❏

❏

❏

Number of active
channels/electrodes

Processing Strategy (default is
HiRes-P)
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Volume Max (default is 20%)

❏

❏

❏

❏

❏

Volume Min (default is 50 %)

❏

❏

❏

❏

❏

Sensitivity (default is 0 dB)

❏

❏

❏

❏

❏

IDR (default is 60 dB)

❏

❏

❏

❏

❏

Audio Mixing (default is 50/50-

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

Filter (default is Extended Low)

❏

❏

❏

❏

❏

AGC (default is 2- Dual Loop)

❏

❏

❏

❏

❏

Mic/Aux)

Mic Mode (default is
Omnidirectional)
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If you do not use the default settings for any of the parameters, what value (or range of
values) you typically use? Please enter in the text boxes below. If it is not applicable,
leave the boxes empty and move to the next question.

Enter

What is your

alternate

reason for

values in the

using

boxes below.

alternate
values?

Number of active channels/electrodes

❏

❏

Processing Strategy (default is HiRes-P)

❏

❏

Clearvoice (default is “Off”)

❏

❏
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Pulse Width (default is APW I)

❏

❏

T Level (default is 10% of M)

❏

❏

Gain (default is 0 for all channels)

❏

❏

Volume Max (default is 20%)

❏

❏

Volume Min (default is 50 %)

❏

❏

Sensitivity (default is 0 dB)

❏

❏

IDR (default is 60 dB)

❏

❏

Audio Mixing (default is 50/50-Mic/Aux)

❏

❏
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Mic Mode (default is Omnidirectional)

❏

❏

Filter (default is Extended Low)

❏

❏

AGC (default is 2- Dual Loop)

❏

❏

The following questions are about mapping Med-EL devices.
Do you work with Med-EL devices?
1.

Yes

2.

No

Which of the following services do you provide for Med-EL patients?
1.

Pre-implantation counseling

2.

Mapping

3.

Troubleshooting

4.

Follow up / fine tuning

82

5.

Aural Rehabilitation

6.

Other

When mapping Med-EL devices how often do you select the default settings for the
following parameters?

I

Almost

Half the Someti

I never

always

always

time

use

mes

use

default

default

settings

settings

No. of active channels /electrodes ❏

❏

❏

❏

❏

❏

❏

❏

❏

(default is 12)

Pulse duration (default is 7.08
microseconds)

❏
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❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

AGC sensitivity (default is 75%)

❏

❏

❏

❏

❏

MapLaw (default is logarithmic

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

Processing Strategy (default is
FS4)

Frequency bands (default is
logarithmic FS—100 to 8500 Hz)

AGC Compression Ratio (default
is 3:1)

with compression=500)

Lock THR Charge (default is
10% of MCL)

Volume Mode (default is IBK)
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Microphone Directionality

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

(default is “Natural”)

Wind noise reduction (default is
“Mild”)

If you do not use the default settings for any of the parameters, what value (or range of
values) you typically use? Please enter in the text boxes below. If it is not applicable,
leave the boxes empty and move to the next question.

Enter

What is your

alternate

reason for

values in the

using

boxes below. alternate
values?
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No. of active channels /electrodes (default is 12)

❏

❏

Pulse duration (default is 7.08 microseconds)

❏

❏

Processing Strategy (default is FS4)

❏

❏

Frequency bands (default is logarithmic FS—100 to

❏

❏

AGC Compression Ratio (default is 3:1)

❏

❏

AGC sensitivity (default is 75%)

❏

❏

MapLaw (default is logarithmic with

❏

❏

❏

❏

8500 Hz)

compression=500)

Lock THR Charge (default is 10% of MCL)
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Volume Mode (default is IBK)

❏

❏

Microphone Directionality (default is “Natural”)

❏

❏

Wind noise reduction (default is “Mild”)

❏

❏

Regardless of the cochlear implant manufacturer, indicate how often you use the
following objective measurements.
PEDIATRIC Patients

Always

Almost

Half the Someti

always

time

mes

Never
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❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

e-ABR in pediatric patients

❏

❏

❏

❏

❏

ESRT (stapedial reflex) in

❏

❏

❏

❏

❏

Vestibular tests (e.g. ENG, VNG) ❏

❏

❏

❏

❏

At mapping visits I measure
electrode impedance in pediatric
patients

ECAP (including NRT, NRI,
ART) in pediatric patients

pediatric patients

ADULT Patients

88

Always

Almost

Half the Someti

always

time

mes

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

e-ABR in adult patients

❏

❏

❏

❏

❏

ESRT (stapedial reflex) in adult

❏

❏

❏

❏

❏

❏

❏

❏

❏

❏

At mapping visits I measure

Never

electrode impedance in adult
patients

ECAP (including NRT, NRI,
ART) in adult patients

patients

Vestibular tests (e.g. ENG,
VNG)
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Bimodal fitting (Hearing aid in the non implanted ear)
How often do you recommend a hearing aid for the non-implanted ear in adult patients?
1.

Always

2.

Most of the time

3.

About half the time

4.

Sometimes

5.

Never

How often do you recommend a hearing aid for the non-implanted ear in pediatric
patients?
1.

Always

2.

Most of the time

3.

About half the time

4.

Sometimes
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5.

Never

When fitting hearing aid on the non-implanted side, which prescriptive formula/e do you
use? (select all that apply)
1.

Manufacturer&#39;s proprietary formula

2.

NAL

3.

DSL

4.

My own gain prescription

Aural Rehabilitation
How often do you recommend the following for pediatric CI patients?

Always Most of About

Speech Thearpy

❏

Once in Never

the

half the a while

time

time

❏

❏

❏

❏
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Computerized Auditory training

❏

❏

❏

❏

❏

How often do you recommend the following for adult CI patients?

Always

Most of About

Once in Never

the

half the

a while

time

time

Speech Thearpy

❏

❏

❏

❏

❏

Computerized Auditory training

❏

❏

❏

❏

❏

We are almost done! Would you like to provide any additional comments? Please use the
box below. Thank you!
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